Note: Marengo Therapeutics's revenues are gauged from an analysis of company filings.
Marengo Therapeutics's Income Statement (based on Industry Averages)
Marengo Therapeutics P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Trademark Applications
Trademark applications show the products and services that Marengo Therapeutics is developing and marketing.
Marengo Therapeutics doesn't have any recent trademark applications, indicating Marengo Therapeutics is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
MARENGO Pharmaceutical preparations for use in immunology and oncology; pharmaceutical preparations for use in treating cancer; pharmaceutical preparations for use in treating malignant tumors; pharmaceutical preparations for the treatment and prevention of cancer and immune system diseases and disorders; pharmaceutical preparations using antibodies to target malignant solid tumors and to promote protective tumor immunity; pharmaceutical preparations for triggering cytokine release for the expansion of an antigen-specific memory T cell repertoire for the purpose of treating cancer; pharmaceutical preparations for immune system activation and protection; pharmaceutical preparations for anti-cancer immune activation therapeutics; pharmaceuticals, namely, antibodies for the treatment of cancer; pharmaceutical preparations for use in the fields of immunology and oncology for treating cancer, infectious disease, auto-immune disease, and other diseases in connection with immune system dysfunction; vaccines; human vaccine preparations
11/05/2021
UNITI Pharmaceuticals, namely, multi-functional proteins for therapeutic use for the treatment of cancer; pharmaceuticals, namely, multi-functional proteins for therapeutic use for the treatment of autoimmune diseases
07/05/2017
See all trademarks and details in the Full Report.
Market Share of Marengo Therapeutics's Largest Competitors
A competitive analysis shows these companies are in the same general field as Marengo Therapeutics, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Marengo Therapeutics.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Marengo Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.